Lv3
260 积分 2022-06-30 加入
Clinical effects of off-label reduced doses of Direct Oral Anticoagulants: A systematic review and meta-analysis
9天前
已完结
Safety and efficacy of direct oral anticoagulants in geriatric patients with non-valvular atrial fibrillation: A single-center retrospective study
9天前
已关闭
Effectiveness and safety of reduced-dose rivaroxaban for elderly patients with non-valvular atrial fibrillation: A subanalysis of the EXPAND study
9天前
已完结
Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach
9天前
已关闭
Off-Label Reduced Dose Apixaban in Older Adults With Atrial Fibrillation and Associated Outcomes
9天前
已完结
Real‐World Edoxaban Concentrations in Older Patients Receiving Reduced‐Dose Regimens
12天前
已关闭
Evaluation of the impact of NOAC underdosing and exploration of bleeding risk factors in elderly patients with atrial fibrillation: artificial intelligence-based approach
12天前
已关闭
Long-Term Clinical Outcomes of Underdosed Direct Oral Anticoagulants in Patients with Atrial Fibrillation and Atrial Flutter
12天前
已完结
Thromboembolic and bleeding events with rivaroxaban in clinical practice in Spain: impact of inappropriate doses (the EMIR study)
12天前
已完结
Assessment of Non-Vitamin K Antagonist Oral Anticoagulant Dosing Patterns in Turkish Patients with Non-Valvular Atrial Fibrillation: A Multicenter, Cross-Sectional Study with Insights from the ASPECT-NOAC Study*
14天前
已关闭
皖公网安备34019202002308
